NOVONIX LTD SP.ADS/4 (GC30) - Total Liabilities
Based on the latest financial reports, NOVONIX LTD SP.ADS/4 (GC30) has total liabilities worth €121.25 Million EUR (≈ $141.75 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of NOVONIX LTD SP.ADS/4 to assess how effectively this company generates cash.
NOVONIX LTD SP.ADS/4 - Total Liabilities Trend (2022–2025)
This chart illustrates how NOVONIX LTD SP.ADS/4's total liabilities have evolved over time, based on quarterly financial data. See shareholders equity of NOVONIX LTD SP.ADS/4 for net asset value and shareholders' equity analysis.
NOVONIX LTD SP.ADS/4 Competitors by Total Liabilities
The table below lists competitors of NOVONIX LTD SP.ADS/4 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Newcore Gold Ltd
V:NCAU
|
Canada | CA$3.64 Million |
|
M.I.TECH Co.Ltd
KQ:179290
|
Korea | ₩13.75 Billion |
|
Atlas Salt Inc
V:SALT
|
Canada | CA$1.81 Million |
|
Magyar Bancorp Inc
NASDAQ:MGYR
|
USA | $923.75 Million |
|
SLOMAN NEPTUN Schiffahrts-Aktiengesellschaft
HM:NEP
|
Germany | €94.77 Million |
|
Icon Group
TA:ICON
|
Israel | ILA364.43 Million |
|
Riverview Bancorp Inc
NASDAQ:RVSB
|
USA | $1.32 Billion |
|
ALT5 Sigma Corporation
NASDAQ:ALTS
|
USA | $64.11 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down NOVONIX LTD SP.ADS/4's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GC30 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NOVONIX LTD SP.ADS/4's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NOVONIX LTD SP.ADS/4 (2022–2025)
The table below shows the annual total liabilities of NOVONIX LTD SP.ADS/4 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | €88.51 Million ≈ $103.47 Million |
+11.46% |
| 2024-06-30 | €79.41 Million ≈ $92.83 Million |
+54.58% |
| 2023-06-30 | €51.37 Million ≈ $60.05 Million |
-0.92% |
| 2022-06-30 | €51.85 Million ≈ $60.61 Million |
-- |
About NOVONIX LTD SP.ADS/4
NOVONIX Limited, a battery technology and materials company, provides products and mission critical services in North America, Asia, Australia, and Europe. It operates through Battery Materials, Battery Technology, and Graphite Exploration segments. The company develops and manufactures battery anode materials and battery cell testing equipment; performs consulting services; and carries out resea… Read more